35 phenotypes from 6 alleles in 10 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Adora2btm1.1(KOMP)Vlcg/Adora2b+ B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J	abnormal retina blood vessel morphology	J:211773
	convulsive seizures	J:211773
	increased fasting circulating glucose level	J:211773
Adora2btm1.1(KOMP)Vlcg/Adora2btm1.1(KOMP)Vlcg B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Adora2btm1.1Msit/Adora2btm1.1Msit either: (involves: C57BL/6) or (involves: C57BL/6 * CD-1 * ICR)	abnormal macrophage physiology	J:169155
	decreased susceptibility to induced morbidity/mortality	J:169155
	decreased susceptibility to injury	J:169155
	increased heart rate	J:169155
	increased interleukin-6 secretion	J:169155
	increased mean systemic arterial blood pressure	J:169155
	increased systemic arterial systolic blood pressure	J:169155
	increased tumor necrosis factor secretion	J:169155
Adora2btm1.1Msit/Adora2btm1.1Msit involves: BALB/cJ	increased susceptibility to injury	J:203572
Adora2btm1Dgen/Adora2btm1Dgen B6.129P2-Adora2btm1Dgen	abnormal dendritic cell physiology	J:138722
	abnormal penile erection	J:135978
	abnormal response to injury	J:131314
	decreased interleukin-10 secretion	J:147023
	increased vascular permeability	J:131314
Adora2btm1Dgen/Adora2btm1Dgen involves: 129P2/OlaHsd	abnormal response to cardiac infarction	J:131444
	decreased susceptibility to injury	J:234143
Adora2btm1Kra/Adora2btm1Kra involves: 129 * C57BL/6J	abnormal cytokine level	J:111715
	abnormal inflammatory response	J:111715
	abnormal interleukin level	J:111715
	abnormal leukocyte adhesion	J:111715
	abnormal leukocyte migration	J:111715
	abnormal tumor necrosis factor level	J:111715
	normal cardiovascular system phenotype	J:111715
	decreased interleukin-10 secretion	J:111715
	enhanced leukocyte tethering or rolling	J:111715
	increased circulating interleukin-6 level	J:111715
Adora2btm1Msit/Adora2btm1Msit Lyz2tm1(cre)Ifo/Lyz2+ involves: 129P2/OlaHsd * C57BL/6	decreased susceptibility to injury	J:169155
Adora2btm1Msit/Adora2btm1Msit Tg(Cdh5-cre)7Mlia/0 involves: FVB/N	normal homeostasis/metabolism phenotype	J:203572
Adora2btm1Msit/Adora2btm1Msit Tg(Sftpc-cre)1Blh/0 involves: C57BL/6 * DBA/2	increased susceptibility to injury	J:203572
Adora2btm1Till/Adora2btm1Till B6.129P2-Adora2btm1Till	abnormal cellular extravasation	J:125297
	decreased physiological sensitivity to xenobiotic	J:125297
	normal homeostasis/metabolism phenotype	J:125297
	impaired adaptive thermogenesis	J:125297
	increased interleukin-6 secretion	J:125297
	increased susceptibility to induced morbidity/mortality	J:125297
	increased susceptibility to type I hypersensitivity reaction	J:125297